HLA and Killer Cell Immunoglobulin-like Receptors Influence the Natural Course of CMV Infection
- 15 April 2014
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 210 (7) , 1083-1089
Abstract
Natural killer (NK) cells provide a major defense against cytomegalovirus (CMV) infection through the interaction of their surface receptors, including the activating and inhibitory killer immunoglobulin-like receptors (KIRs), and human leukocyte antigens (HLA) class I molecules. This study assessed whether the KIR and HLA repertoire may influence the risk of developing symptomatic or asymptomatic disease after primary CMV infection in the immunocompetent host. Sixty immunocompetent patients with primary symptomatic CMV infection were genotyped for KIR and their HLA ligands, along with 60 subjects with a previous asymptomatic infection as controls. The frequency of the homozygous A haplotype (only KIR2DS4 as activating KIR) was higher in symptomatic patients than controls (30% vs 12%, respectively; odds ratio [OR] = 3.24; P = .01). By logistic regression, the risk of developing symptomatic disease was associated with the homozygous A haplotype and the HLABw4(T) allele. Combining the 2 independent variables, we found that 37 out of 60 (62%) symptomatic patients but only 18 out of 60 (30%) of controls possessed the homozygous A haplotype or the HLABw4(T) allele with a highly significant OR (OR = 3.75, P < .0005). Immunocompetent subjects carrying the homozygous A haplotype or the HLABw4(T) allele are at higher risk of developing symptomatic disease after primary CMV infection.Keywords
This publication has 25 references indexed in Scilit:
- Natural Killer Cell Receptor Repertoire and Their Ligands, and the Risk of CMV Infection After Kidney TransplantationAmerican Journal of Transplantation, 2008
- The Yin and Yang of HLA and KIR in human diseaseSeminars in Immunology, 2008
- The Number of Activating KIR Genes Inversely Correlates with the Rate of CMV Infection/Reactivation in Kidney Transplant RecipientsAmerican Journal of Transplantation, 2008
- Differential natural killer cell–mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypesJournal of Experimental Medicine, 2007
- Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1Nature Genetics, 2007
- KIR/HLA Pleiotropism: Protection against Both HIV and Opportunistic InfectionsPLOS Pathogens, 2006
- Killer immunoglobulin-like receptors and HLA act both independently and synergistically to modify HIV disease progressionGenes & Immunity, 2005
- Severe Cytomegalovirus Infection in Immunocompetent PatientsClinical Infectious Diseases, 1997
- Threonine 80 on HLA‐B27 confers protection against lysis by a group of natural killer clonesEuropean Journal of Immunology, 1996
- Severe Herpesvirus Infections in an Adolescent without Natural Killer CellsNew England Journal of Medicine, 1989